5 p

dasatinib resistance in patients with chronic myelogenous leukemia identification of a novel bcr-abl kinase domain mutation

3 p

dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the t315i bcr-abl1 mutation

6 p

association of adiponectin and amino terminal probnp in peripheral arterial disease

13 p

association of acylated cationic decapeptides with dipalmitoylphosphatidylserine–dipalmitoylphosphatidylcholine lipid membranes

7 p

advanced oxidation processes for the treatment of olive-oil mills wastewater

8 p

advanced oxidation of natural organic matter using hydrogen peroxide and iron-coated pumice particles

7 p

clinical laboratory application of a reporter-gene assay for measurement of functional activity and neutralizing antibody response to infliximab

15 p

clinical laboratory advances in the detection of rabies virus